SCHEMBL4555845

SCHEMBL4555845

N#CC1(c2ccccc2Cl)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 3/20 0.41
ADRA1D P25100 2/20 0.41
ADRA1B P35368 2/20 0.41
SCD O00767 1/20 0.41
HDAC4 P56524 1/20 0.40
BDKRB1 P46663 1/20 0.38
OPRM1 P35372 2/20 0.38
OPRL1 P41146 2/20 0.37
SLC6A4 P31645 2/20 0.37
GRIN1 Q05586 2/20 0.37
GRIN2A Q12879 2/20 0.37
LMNA P02545 2/20 0.37
OPRK1 P41145 1/20 0.37
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GRIN2B Q13224 1/20 0.37
CACNA1C Q13936 1/20 0.37
GRIN2C Q14957 1/20 0.37
GRIN3A Q8TCU5 1/20 0.37
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31459475 1.00 ADRA1A (0.41) ADRA1AADRA1DADRA1BSCDHDAC4
SCHEMBL8747130 0.92 HDAC4 (0.45) ADRA1AADRA1DADRA1BSCDHDAC4
SCHEMBL18742441 0.92 HDAC4 (0.41) ADRA1AADRA1DADRA1BSCDHDAC4
SCHEMBL7963694 0.87 ADRA1A (0.38) ADRA1AADRA1DADRA1BSCDHDAC4
SCHEMBL28689514 0.87 SCD (0.40) ADRA1AADRA1DADRA1BSCDHDAC4
SCHEMBL10297980 0.86 ADRA1A (0.44) ADRA1AADRA1DADRA1BSCDOPRM1
Hydrochloric Acid SCHEMBL30389297 0.86 ADRA1A (0.37) ADRA1AADRA1DADRA1BSCDHDAC4
Hydrochloric Acid SCHEMBL3177020 0.86 ADRA1A (0.37) ADRA1AADRA1DADRA1BSCDHDAC4
SCHEMBL2288498 0.86 ADRA1A (0.42) ADRA1AADRA1DADRA1BSCDHDAC4
SCHEMBL6884854 0.84 OPRM1 (0.56) ADRA1AADRA1DADRA1BSCDOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4859232-A Substituted-aryl cyclopropanecarbonitriles and derivatives thereof as herbicide antidotes MONSANTO COMPANY (US) 1989-08-22 US claimed
CN-113861072-A Preparation method of aryl cyclopropane compound 上海麦克林生化科技有限公司 2021-12-31 CN disclosed
EP-2134692-A2 QUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR SELECTIN INHIBITION Wyeth a Corporation of the State of Delaware (US) 2009-12-23 EP disclosed
US-20080255192-A1 2-(1-(4-chlorophenyl)cyclopropyl)-3-hydroxy-8-(trifluoromethoxy)quinoline-4-carboxylic acid; antiinflammtory agents; antagonists of the mammalian adhesion proteins WYETH (US) 2008-10-16 US disclosed
WO-2008121817-A2 QUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR SELECTIN INHIBITION WYETH (US) 2008-10-09 WO disclosed
CN-1915231-A Use of nonsteroidal in preparing drug of antiinflammatory agents SCHERING AG (DE) 2007-02-21 CN disclosed
US-7166592-B2 Antiinflammatory agents SCHERING AKTIENGESELLSCHAFT (DE) 2007-01-23 US disclosed
US-7129270-B2 Nonsteroidal antiinflammatory agents Schėring AG (DE) 2006-10-31 US disclosed
EP-1046635-B1 Process for preparing an aromatic compound substituted by a tertiary nitrile PFIZER PROD INC (US) 2004-12-29 EP disclosed
US-20040254249-A1 Nonsteroidal antiinflammatory agents JAROCH STEFAN (DE) 2004-12-16 US disclosed
CN-1444570-A Non-steroidal anti-inflammatory drugs SCHERING AG (DE) 2003-09-24 CN disclosed
EP-1309571-A1 NON-STEROIDAL INFLAMMATION INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2003-05-14 EP disclosed
US-20020077356-A1 Nonsteroidal antiinflammatory agents SCHERING AKTIENGESELLSCHAFT (DE) 2002-06-20 US disclosed
WO-2002010143-A1 NON-STEROIDAL INFLAMMATION INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2002-02-07 WO disclosed
US-6303782-B1 TREATING A FLUORINE-SUBSTITUTED AROMATIC COMPOUND WITH A SECONDARY NITRILE IN THE PRESENCE OF A BASE PFIZER INC 2001-10-16 US disclosed
EP-1046635-A1 Process for preparing an aromatic compound substituted by a tertiary nitrile Pfizer Products Inc. (US) 2000-10-25 EP disclosed
EP-0310954-B1 ORTHO-SUBSTITUTED CARBOXYLIC ACID BENZYL ESTERS AND FUNGICIDES CONTAINING THESE COMPOUNDS BASF Aktiengesellschaft (DE) 1990-11-22 EP disclosed
US-4952720-A Ortho-substituted benzyl carboxylates and fungicides which contain these compounds BASF AKTIENGSELLSCHAFT (DE) 1990-08-28 US disclosed
US-4859232-A Substituted-aryl cyclopropanecarbonitriles and derivatives thereof as herbicide antidotes MONSANTO COMPANY (US) 1989-08-22 US disclosed
EP-0310954-A1 Ortho-substituted carboxylic acid benzyl esters and fungicides containing these compounds BASF Aktiengesellschaft (DE) 1989-04-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020077356-A1 Nonsteroidal antiinflammatory agents PTGS1, PTGES2, PTGES ADRA1A 471/4885ADRA1D 663/4885ADRA1B 754/4885
US-20080255192-A1 2-(1-(4-chlorophenyl)cyclopropyl)-3-hydroxy-8-(trifluoromethoxy)quinoline-4-carboxylic acid; antiinflammtory agents; antagonists of the mammalian adhesion proteins VCAM1, ICAM1, SELE ADRA1A 898/4885ADRA1D 1029/4885ADRA1B 1123/4885
US-20040254249-A1 Nonsteroidal antiinflammatory agents PTGS1, PTGER1, PTGES2 ADRA1A 473/4885ADRA1D 557/4885ADRA1B 765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.